MRI study to evaluate 0.025 mmol/kg BW Gd-EOB-DTPA (SH L 569 B) and 0.05 mmol/kg BW Gd-BOPTA (Gadobenate Dimeglumine) in patients with known or suspected focal liver lesions
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Multicenter, double-blind, randomized, inter-individual comparison study in MRI with a corresponding blinded reading to evaluate 0.025 mmol/kg BW Gd-EOB-DTPA (SH L 569 B) and 0.05 mmol/kg BW Gd-BOPTA (gadobenate dimeglumine) after a single i.v. injection